Elkind-Hirsch, Karen

Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome

Elkind-Hirsch, K., Marrioneaux, O., Bhushan, M., Vernor, D., & Bhushan, R. (2008) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 276

Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study

Elkind-Hirsch, K. E., Chappell, N., Shaler, D., Storment, J., & Bellanger, D. (2022) · Fertility and Sterility

Ovarian function and disordersPharmacology and Obesity Treatment

Cited by 182

Exenatide, dapagliflozin, or Phentermine/Topiramate differentially affect metabolic profiles in polycystic ovary syndrome

Elkind-Hirsch, K. E., Chappell, N., Seidemann, E., Storment, J., & Bellanger, D. (2021) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes Treatment and Management

Cited by 96

Aerobic exercise in women with polycystic ovary syndrome improves ovarian morphology independent of changes in body composition

Redman, L. M., Elkind-Hirsch, K., & Ravussin, E. (2011) · Fertility and Sterility

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 44

The endocrine effects of spironolactone used as an antiandrogen

Young, R. L., Goldzieher, J. W., & Elkind-Hirsch, K. (1987) · Fertility and Sterility

Ovarian function and disordersAdrenal Hormones and Disorders

Cited by 38